Show Summary Details
Page of

Antimicrobial chemotherapy 

Antimicrobial chemotherapy
Antimicrobial chemotherapy

R.G. Finch



Addition of new treatments for HCV and HIV; addition of echinocandins; update on antimalarials; novel antituberculosis agents; emergence of drug-resistant organisms, e.g. XDR TB, VISA, and VRSA.

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 20 September 2021

The practice of medicine changed dramatically with the availability of effective antimicrobial agents. Fatal diseases such as bacterial meningitis and endocarditis became treatable; much minor community infectious morbidity became readily controlled; many surgical procedures became much safer, and developments in solid organ and bone marrow transplantation became possible. However, the very success of antimicrobial chemotherapy has led to overuse, misuse and inappropriate pressures from the public to prescribe. In many countries, antibiotics are freely available to the public for purchase ‘over the counter’, with few controls or guidance to ensure their safe and effective use. The emergence and spread of antimicrobial resistance worldwide and the decline in development and licensing of new antimicrobials threaten the future successful treatment of bacterial infections....

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.